Offers unrivaled quality, reliability and compliance

We aim to emerge as a dynamic pharmaceutical production unit that has sustainable partnerships with major international companies in the field of pharmaceutical manufacturing.

About Mac & Rains Pharma

Mac & Rains Pharmaceuticals came into existence in 2002 as a private limited company. The main purpose of establishing the company was to produce complete pharmaceutical range products and supply it in the locals market as well as abroad.

The factory design, engineering and the systems have been designed and modified under the absolute guidance of world leaders of the pharma consultancy. With continuous efforts, the company has successfully progressed towards its motto: ‘LIFE FLOWS FROM TECHNOLOGICAL EXCELLENCE’.

Mac & Rains Pharmaceuticals is a business unit of Mac & Rains group of companies. It offers unrivaled quality, reliability and compliance, with a reputation for scientific and technical excellence. Because of this today, we look at our past with pride and future with optimism while confronting the challenges of present with effectiveness.  At Mac & Rains, we aim to emerge as a dynamic pharmaceutical production unit that has sustainable partnerships with major international companies in the field of pharmaceutical manufacturing.

Vision

To be ranked among the global top ranked, leading  pharmaceutical companies in the pharmaceutical and healthcare industry. To create value incessantly and bring pride to our stakeholders, partners, customers and the community at large. To provide sustainable medicines to improvise and save human lives to honor our motto of “Ode to life”.

Mission

We are a revered and reputed organization dealing in manufacturing of various segments of pharmaceutical production. through effective management capability, efficient processes and smart technologies. We ensure the product quality through the strict criterion defined by the international pharmacopeias. Our outstanding performance is led by entrepreneurial culture, hard work and discipline. All our operations are achieved in a manner of fairness, honesty and corporate responsibility.

Quality Policy

At Mac & Rains(Pvt.) Ltd. we are unconditionally committed towards focusing our resource pool, skills and efforts to continuously improve upon solutions, product quality and services through managing our internal and external policies, procedures and processes for the benefit of our customers.

The principle objectives of our quality policy are as follow:

  • Sustaining high “Do it right the first time” record of achievement and effectiveness
  • Incorporate cGMP requirements as a unified system in all business processes
  • Continuously improve the operational systems to enhance the quality of products along with cost effectiveness and health care solutions
  • Carrying out regular training programs for employees to improve their knowledge, productivity and effectiveness
  • Implementing policies that are responsive towards environment, health and safety

Corporate Social Responsibility

Mac & Rains(Pvt.) Ltd. remains committed to establish, operate and maintain high standards of environmental and occupational health and safety at work. These standards show continuous improvement while drastically reducing pollution, risks related to personal injury, damage to health and minimizing of the financial losses. Our aim is to safeguard the wellbeing of those working at, visiting and living near our premises.

INBUFIN

(Ibuprofen IV Infusion 100ML Vial)

Searle IV Solutions has achieved an unprecedented groundbreaking milestone in healthcare sector by being first in the country and only the second company in world to successfully manufacture ready to use Ibuprofen IV Infusion(100 ML), an FDA approved revolutionary research product for pain management. This is a huge achievement not just for the company but for an under developed country like Pakistan. Launched in the last quarter of 2019, INBUFIN has already shown potential to become one of the biggest brands in the country’s pharmaceutical sector in this short time.  It has also become the strongest product of the company.

Interestingly, Abbott International, the inventors of ibuprofen SALT, have contacted SEARLE IV time and again to acquire the marketing rights of INBUFIN. They have been trying to perfect the formulation for this product since the past THREE DECADES to no avail. As per the company’s stance to take forward INBUFIN independently, the offer was declined. 

Also, the inventor of this product has personally visited our plant and  transferred the technology and formulation to our Group Chairman, Mr. Mansoor Dilawar’s youngest son Dr. Asim Hassan – Deputy Director Technical, who is a Doctor in Pharmacy. Currently he is the only one in our company with technical skills and complete knowledge of its manufacturing process and formulation. Inbufin will play a vital role as the company stride forwards. INBUFIN has already gathered attention from international arena and we have started its export in various countries like; Tajikistan, Iraq, Cambodia, Oman and Afghanistan.

We can foresee the potential of INBUFIN is to reach PKR ONE BILLION InshAllah by the year 2025.

MACMOL

(Paracetamol IV Infusion 100 ML Vial)

Our main area of expertise is based on an in-depth knowledge of “Sterile Vial filling” mainly because we have been involved in large volume IV Infusion business for last 15 years and possess the technology and a technical team enabling us to excel.

Searle IV Solutions started promotional marketing for their pharmaceutical products in 2015, One product to stand out immediately  was Macmol IV Infusion. Owing to our wide experience and expertise,

This paracetamol infusion is formulated by using the best grade ingredients and sophisticated techniques. Due to its supreme quality and tireless efforts of marketing and promotion team, MACMOL became third bestselling brand in its division in Pakistan and will become number Two within a year.

We had tremendous success in Export of this product as well as it has become n number one bestselling brand in Afghanistan.

Our forecast for MACMOL is to reach PKR ONE BILLION InshAllah by the year 2025.

Our Products